Channel Therapeutics Corporation - CHRO

SEC Filings Our CHRO Tweets

About Gravity Analytica

Recent News

  • 09.05.2026 - CXM: 4 Powerful Benefits of Customer Experience Management
  • 08.29.2026 - Turbocharge Your Marketing with an Identity Intelligence Platform
  • 08.14.2026 - Data Enrichment: Up Your Marketing Strategy with Reliable Insights
  • 08.07.2026 - How Identity Marketing is Transforming the Industry
  • 07.31.2026 - A Personalized Customer Experience: How to Use Data Responsibly
  • 07.24.2026 - Data Lineage: The Missing Link to Your Data Strategy
  • 07.07.2026 - Customer Data Debt: How to Solve this Growing Concern
  • 07.03.2026 - Identity-Based Marketing: The Secret Sauce to Results
  • 06.26.2026 - Audience Curation Vs. Audience Resolution: Understanding the Differences
  • 06.24.2026 - VisitIQ Appoints Conner Roos as Chief Financial Officer

Recent Filings

  • 08.18.2026 - ARS Annual Report to Security Holders
  • 08.18.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 08.18.2026 - DEF 14A Other definitive proxy statements
  • 08.13.2026 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
  • 08.13.2026 - 8-K Current report
  • 08.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.13.2026 - EX-99.1 EX-99.1
  • 08.13.2026 - 8-K Current report
  • 08.07.2026 - PRE 14A Other preliminary proxy statements
  • 07.07.2026 - 4 Statement of changes in beneficial ownership of securities